TECH vs TENX · P/E 65, rev $1.22B vs P/E 3.4, $24.1M cap
Bio-Techne Corp (TECH) versus Tenax Therapeutics Inc (TENX) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Tenax Therapeutics Inc (TENX) is a biotechnology company listed on US.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported TENX revenue for 2025-09-30 was $0. Net income was -$37.1M. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
Not investment advice. Open the TECH and TENX stock pages for the full models.
Not investment advice.